uShip, an Austin, Texas- and Amsterdam, The Netherlands-based online shipping marketplace and freight automation software provider, closed a $25M Series D funding.
Plays.tv, a Redwood City, CA-based platform for players to record, replay, and relive their games, raised $15m in Series A funding.
Mylestone, a Boston, MA-based platform that makes memories accessible via Amazon’s Alexa and other virtual assistants, raised $2.5m in funding.
Opal, a Portland, Oregon-based collaboration platform for brand marketing teams, raised $15.5m in Series B funding.
StockX, a Detroit, MI-based online consumer “stock market of things”, closed a $6m round of funding.
Immuta, a College Park, Maryland-based data platform, secured $8m in Series A funding.
Brightwheel, a San Francisco, CA-based provider of management and communication software for early education, raised $10m in Series A financing.
TetraVue, a Carlsbad, CA-based developer of Ultra High Definition, Solid State Flash LIDAR* for autonomous car manufacturers, closed a $10M Series A funding.
Xsolla, Inc., a Los Angeles, CA-based an e-commerce platform for video game publishing and distribution, has launched a $30m fund.
OpenFin, a New York – based common operating layer for financial desktop applications, raised $15m in Series B funding.
Dermata Therapeutics, LLC, a San Diego, CA-based biotechnology company developing new and innovative products to treat a variety of dermatological diseases, completed a $5m Series 1a financing.
Rhythm, a Boston, MA-based biopharmaceutical company developing peptide therapeutics for rare genetic deficiencies that result in life-threatening metabolic disorders, completed a $41m mezzanine round of financing.
ReplyYes, a Seattle, WA-based e-commerce over mobile messaging platform for brands to engage and transact with their customers, raised $6.5m in Series A funding.
Paradigm Diagnostics, a Phoenix, AZ-based provider of a cancer diagnostic test, near completed its $7M Series B financing.
Xcell Biosciences, a San Francisco, CA-based provider of an advanced primary cell culturing platform, closed a $12m Series A private equity financing round.